1,478
Views
26
CrossRef citations to date
0
Altmetric
Editorial

BDNF/TrkB signaling as an anti-tumor target

, , , &
Pages 1473-1475 | Published online: 10 Jan 2014

References

  • Yoshii A, Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev. Neurobiol.70, 304–322 (2010).
  • Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem.72, 609–642 (2003).
  • Thiele CJ, Li Z, McKee AE. On Trk – the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin. Cancer Res.15, 5962–5967 (2009).
  • Desmet CJ, Peeper DS. The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell. Mol. Life Sci.63, 755–759 (2006).
  • Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett.169, 107–114 (2001).
  • Li Z, Oh DY, Nakamura K, Thiele CJ. Perifosine-induced inhibition of AKT attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer DOI: 10.1002/cncr.26133 (2011) (Epub ahead of print).
  • Schmidt AL, de Farias CB, Abujamra AL et al. BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells. J. Mol. Neurosci.40, 303–310 (2010).
  • Perez-Pinera P, Hernandez T, García-Suárez O et al. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol. Cell Biochem.295, 19–26 (2007).
  • Harada T, Yatabe Y, Takeshita M et al. Role and relevance of TrkB mutations and expression in non-small cell lung cancer. Clin. Cancer Res.17, 2638–2645 (2011).
  • Lai PC, Chiu TH, Huang YT. Overexpression of BDNF and TrkB in human bladder cancer specimens. Oncol. Rep.24, 1265–1270 (2010).
  • Huang YT, Lai PC, Wu CC et al. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells. Int. J. Oncol.36, 1469–1476 (2010).
  • Huang YT, Lai PC, Wu CC, Cheng CC, Chiu TH. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells. Int. J. Oncol.37, 943–949 (2010).
  • Vanhecke E, Adriaenssens E, Verbeke S et al. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin. Cancer Res.17, 1741–1752 (2011).
  • Patani N, Jiang WG, Mokbel K. Brain-derived neurotrophic factor expression predicts adverse pathological and clinical outcomes in human breast cancer. Cancer Cell. Int.11(1), 23 (2011).
  • Moon A, Won KY, Lee JY, Kang I, Lee SK, Lee J. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix. Pathology43, 453–458 (2011).
  • Yang ZF, Ho DW, Lam CT et al. Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res.65, 219–225 (2005).
  • Bardelli A, Parsons DW, Silliman N et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science300, 949 (2003).
  • Geiger TR, Song JY, Rosado A, Peeper DS. Functional characterization of human cancer-derived TrkB mutations. PLoS One6, e16871 (2011).
  • de Farias CB, Rosemberg DB, Heinen TE et al. BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer. Oncology79, 430–439 (2010).
  • Lam CT, Yang ZF, Lau CK, Tam KH, Fan ST, Poon RT. Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma. Clin. Cancer Res.17, 3123–3133 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.